We are live on
!
Find out more
SGH
Sivik Global Healthcare Portfolio holdings
AUM
$132M
1-Year Est. Return
24.1%
This Fund
S&P 500
This Quarter
Est. Return
+12.41%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$141M
AUM Growth
–
Cap. Flow
+$134M
Cap. Flow
% of AUM
94.94%
Top 10 Holdings %
Top 10 Hldgs %
29.66%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$5.08M |
| 2 |
Centene
CNC
|
+$5.02M |
| 3 |
Universal Health Services
UHS
|
+$4.47M |
| 4 |
Community Health Systems
CYH
|
+$4.34M |
| 5 |
Tenet Healthcare
THC
|
+$4.14M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.01% |
| 2 | Financials | 3.7% |
| 3 | Consumer Staples | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
HCA Healthcare
HCA
$87.2B
| $5.25M | 3.73% |
+110,000
| New | +$5.08M |
|
|
2
Centene
CNC
$30.7B
| $4.95M | 3.52% |
+335,816
| New | +$5.02M |
|
|
3
Universal Health Services
UHS
$10.2B
| $4.55M | 3.23% |
+56,000
| New | +$4.47M |
|
|
LPNT
4
DELISTED
LifePoint Health, Inc.
LPNT
| $4.23M | 3% |
+80,000
| New | +$4.02M |
|
|
5
Community Health Systems
CYH
$393M
| $4.1M | 2.91% |
+126,203
| New | +$4.34M |
|
|
6
Tenet Healthcare
THC
$20.5B
| $4M | 2.84% |
+95,000
| New | +$4.14M |
|
7
Bristol-Myers Squibb
BMY
$133B
| $3.99M | 2.83% |
+75,000
| New | +$3.82M |
|
8
Humana
HUM
$43.7B
| $3.61M | 2.57% |
+35,000
| New | +$3.43M |
|
9
CVS Health
CVS
$133B
| $3.58M | 2.54% |
+50,000
| New | +$3.21M |
|
10
Molina Healthcare
MOH
$10.2B
| $3.48M | 2.47% |
+100,000
| New | +$3.37M |
|
11
Gilead Sciences
GILD
$162B
| $3.38M | 2.4% |
+45,000
| New | +$3.13M |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $3.38M | 2.4% |
+40,000
| New | +$3.17M |
|
13
Thermo Fisher Scientific
TMO
$213B
| $3.34M | 2.37% |
+30,000
| New | +$2.98M |
|
|
MDVN
14
DELISTED
MEDIVATION, INC.
MDVN
| $3.19M | 2.27% |
+100,000
| New | +$3.02M |
|
15
AbbVie
ABBV
$443B
| $3.17M | 2.25% |
+60,000
| New | +$2.95M |
|
|
ESRX
16
DELISTED
Express Scripts Holding Company
ESRX
| $3.14M | 2.23% |
+44,700
| New | +$2.92M |
|
17
Cencora
COR
$60.6B
| $3.1M | 2.2% |
+44,099
| New | +$2.96M |
|
|
FRX
18
DELISTED
FOREST LABORATORIES INC
FRX
| $3M | 2.13% |
+50,000
| New | +$2.52M |
|
19
McKesson
MCK
$100B
| $2.9M | 2.06% |
+18,000
| New | +$2.76M |
|
|
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
| $2.87M | 2.04% |
+50,000
| New | +$2.91M |
|
21
Smith & Nephew
SNN
$13.3B
| $2.87M | 2.04% |
+100,000
| New | +$2.64M |
|
22
Agilent Technologies
A
$39.1B
| $2.86M | 2.03% |
+69,900
| New | +$2.66M |
|
23
Biogen
BIIB
$30B
| $2.8M | 1.99% |
+10,000
| New | +$2.59M |
|
24
Zimmer Biomet
ZBH
$18.2B
| $2.8M | 1.99% |
+30,900
| New | +$2.67M |
|
|
AET
25
DELISTED
Aetna Inc
AET
| $2.74M | 1.95% |
+40,000
| New | +$2.61M |
|
Similar funds
RSF
VF
AFP
GCM
TCPW
GCM
FF
PF
Sivik Global Healthcare's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Sivik Global Healthcare, which disclosed 57 positions worth $141M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is HCA Healthcare: 110,000 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, followed by Financials and Consumer Staples.
- Sivik Global Healthcare's largest Q4 2013 buy was HCA Healthcare: 110,000 shares worth $5.25M.
- Sivik Global Healthcare's ten largest holdings make up 30% of its $141M portfolio in Q4 2013.
- Sivik Global Healthcare disclosed 57 positions in Q4 2013, its first 13F filing on record.
Based on Sivik Global Healthcare's 13F filing for Q4 2013, filed 10 Jan 2014.